Dr. Martha L Arellano MD Hematologist

Dr. Martha Arellano is a hematologist in Atlanta, Georgia. She is affiliated with multiple hospitals in the area, including Emory University Hospital and Emory University Hospital Midtown. She received her medical degree from Emory University School of Medicine and has been in practice for 14 years. She is one of 42 doctors at Emory University Hospital and one of 26 at Emory University Hospital Midtown who specialize in Hematology.

Are you Dr. Martha Arellano? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

Emory University Hospital Midtown
High performing in Cancer

Emory University Hospital
Ranked #44 in Cancer

Grady Memorial Hospital

Education & Medical Training

Emory University
Residency, Internal Medicine, 2000 - 2003

Emory University
Fellowship, Hematology/Oncology, 2003 - 2006

Emory University School of Medicine
Class of 2000

Certifications & Licensure

American Board of Internal Medicine
Certified in Cardiovascular Disease

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Interventional Cardiology

WI State Medical License
Active through 2013

Publications & Presentations

Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex.
Fan, J.,Shan, C.,Kang, H. B.,Elf, S.,Xie, J.,Tucker, M.,Gu, T. L.,Aguiar, M.,Lonning, S.,Chen, H.,Mohammadi, M.,Britton, L. M.,Garcia, B. A.,Alečković, M.,Kang, Y.,Kaluz, S.,Devi, N.,Van Meir, E. G.,Hitosugi, T.,Seo, J. H.,Lonial, S.,Gaddh, M.,Arellano, M.,Khoury, H. J.,Khuri, F. R.,Boggon, T. J.,Kang, S.,Chen, J.

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.
Bachanova, V.,Marks, D. I.,Zhang, M. J.,Wang, H.,de Lima, M.,Aljurf, M. D.,Arellano, M.,Artz, A. S.,Bacher, U.,Cahn, J. Y.,Chen, Y. B.,Copelan, E. A.,Drobyski, W. R.,Gale, R. P.,Greer, J. P.,Gupta, V.,Hale, G. A.,Kebriaei, P.,Lazarus, H. M.,Lewis, I. D.,Lewis, V. A.,Liesveld, J. L.,Litzow, M. R.,Loren, A. W.,Miller, A. M.,Norkin, M.,Oran, B.,Pidala, J.,Rowe, J. M.,Savani, B. N.,Saber, W.,Vij, R.,Waller, E. K.,Wiernik, P. H.,Weisdorf, D. J.

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun, A. G.,Gleason, S.,Arellano, M.,Langston, A. A.,McLemore, M. L.,Gaddh, M.,El Rassi, F.,Bernal-Mizrachi, L.,Galipeau, J.,Heffner, L. T.,Winton, E. F.,Khoury, H. J.

See all 25 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA Open Access
  • Coventry Health Care PPO Platinum
  • First Health PPO
  • HealthLink PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by



Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.